LagaƱa, Rejohn A.
HRN: 23-17-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2023
AMPICILLIN 1GM (VIAL)
06/22/2023
06/29/2023
IV
105mg
Q12
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes